Department of Reproductive Medicine, Zigong Hospital of Women and Children Health Care, Zigong, Sichuan, China.
Department of Urology, Zigong Fourth People's Hospital, Zigong, Sichuan, China.
PeerJ. 2024 Jul 11;12:e17706. doi: 10.7717/peerj.17706. eCollection 2024.
To evaluate the efficacy of peri-trigger female reproductive hormones (FRHs) in the prediction of oocyte maturation in normal ovarian reserve patients during the fertilization-embryo transfer (IVF-ET) procedure.
A hospital database was used to extract data on IVF-ET cases from January 2020 to September 2021. The levels of female reproductive hormones, including estradiol (E2), luteinizing hormone (LH), progesterone (P), and follicle-stimulating hormone (FSH), were initially evaluated at baseline, the day of the trigger, the day after the trigger, and the day of oocyte retrieval. The relative change in E2, LH, P, FSH between time point 1 (the day of trigger and baseline) and time point 2 (the day after the trigger and day on the trigger) was defined as E2_RoV1/2, LH_RoV1/2, P_RoV1/2, and FSH_RoV1/2, respectively. Univariable and multivariable regression were performed to screen the peri-trigger FRHs for the prediction of oocyte maturation.
A total of 118 patients were enrolled in our study. Univariable analysis revealed significant associations between E2_RoV1 and the rate of MII oocytes in the GnRH-agonist protocol group ( < 0.05), but not in the GnRH-antagonist protocol group. Conversely, P_RoV2 emerged as a potential predictor for the rate of MII oocytes in both protocol groups ( < 0.05). Multivariable analysis confirmed the significance of P_RoV2 in predicting oocyte maturation rate in both groups ( < 0.05), while the association of E2_RoV1 was not significant in either group. However, within the subgroup of high P_RoV2 in the GnRH-agonist protocol group, association was not observed to be significant. The C-index was 0.83 (95% CI [0.73-0.92]) for the GnRH-agonist protocol group and 0.77 (95% CI [0.63-0.90]) for the GnRH-antagonist protocol group. The ROC curve analysis further supported the satisfactory performance of the models, with area under the curve (AUC) values of 0.79 for the GnRH-agonist protocol group and 0.81 for the GnRH-antagonist protocol group.
P_RoV2 showed significant predictive value for oocyte maturation in both GnRH-agonist and GnRH-antagonist protocol groups, which enhances the understanding of evaluating oocyte maturation and inform individualized treatment protocols in controlled ovarian hyperstimulation during IVF-ET for normal ovarian reserve patients.
评估触发前女性生殖激素(FRH)在预测正常卵巢储备患者体外受精-胚胎移植(IVF-ET)过程中卵母细胞成熟中的作用。
利用医院数据库提取 2020 年 1 月至 2021 年 9 月期间 IVF-ET 病例的数据。基线、触发日、触发后日和卵母细胞采集日评估 FRH 水平,包括雌二醇(E2)、促黄体生成素(LH)、孕酮(P)和卵泡刺激素(FSH)。将时间点 1(触发日和基线)和时间点 2(触发后日和触发日)之间 E2、LH、P、FSH 的相对变化分别定义为 E2_RoV1/2、LH_RoV1/2、P_RoV1/2 和 FSH_RoV1/2。采用单变量和多变量回归筛选预测卵母细胞成熟的触发前 FRH。
共纳入 118 例患者。单变量分析显示,在 GnRH 激动剂方案组中,E2_RoV1 与 MII 卵母细胞率呈显著相关(<0.05),但在 GnRH 拮抗剂方案组中无显著相关性。相反,P_RoV2 是两种方案组中预测 MII 卵母细胞率的潜在预测因子(<0.05)。多变量分析证实,P_RoV2 在两组中预测卵母细胞成熟率均具有统计学意义(<0.05),而 E2_RoV1 在两组中均无统计学意义。然而,在 GnRH 激动剂方案组中,P_RoV2 较高的亚组中,其相关性无统计学意义。GnRH 激动剂方案组的 C 指数为 0.83(95%CI[0.73-0.92]),GnRH 拮抗剂方案组为 0.77(95%CI[0.63-0.90])。ROC 曲线分析进一步支持模型的良好性能,GnRH 激动剂方案组的 AUC 值为 0.79,GnRH 拮抗剂方案组的 AUC 值为 0.81。
P_RoV2 对 GnRH 激动剂和 GnRH 拮抗剂方案组的卵母细胞成熟均具有显著的预测价值,这增强了我们对评估卵母细胞成熟的理解,并为正常卵巢储备患者 IVF-ET 中控制性卵巢刺激提供了个体化治疗方案。